Lumanity will be sponsoring, attending, and presenting at the 2025 LSX World Congress USA meeting where “leaders from the US biotech, medtech, and pharmatech sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology.”
Presentations:
Thriving in Turbulence: Commercial Mastery for the Next Biotech Era
September 17, 2025 | 11:50 am – 12:40 pm
In an increasingly complex funding landscape, biotech companies face unprecedented challenges in maximizing asset value while building sustainable organizational foundations. This timely panel brings together industry veterans who have successfully navigated market volatility to share practical strategies for commercial optimization and organizational resilience. As investor expectations evolve and partnership models transform, executives must balance immediate commercial imperatives with long-term capability building to ensure continued growth and innovation.
- Maximizing Asset Value in Capital-Constrained Markets – Innovative approaches to demonstrate and enhance value when traditional funding channels tighten.
- Embedding Commercial Thinking Early – How commercial considerations in early development create differentiated assets and prevent costly late-stage pivots.
- Build vs. Partner: Finding the Right Balance – Strategic decisions on when to develop internal capabilities versus leveraging external partnerships for commercial success.
- Future-Proofing Commercial Strategy – Creating adaptable commercial frameworks that can evolve with changing market dynamics and stakeholder expectations.
Reach out to Michael Rice directly to set up a meeting, or email contact@lumanity.com.